Edition:
United States

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.81USD
15 Dec 2017
Change (% chg)

$0.07 (+10.06%)
Prev Close
$0.74
Open
$0.74
Day's High
$0.86
Day's Low
$0.73
Volume
54,921
Avg. Vol
46,433
52-wk High
$3.11
52-wk Low
$0.70

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Aug '17 1.19 -0.083
May '17 2.00 -0.059
Feb '17 1.24 -0.066
FY 2016 Nov '16 0.57 -0.134
Aug '16 0.55 -0.074
May '16 0.56 -0.081
Feb '16 0.57 -0.087
FY 2015 Nov '15 0.85 -0.128
Aug '15 0.84 -0.079
May '15 1.27 -0.064
Feb '15 1.14 -0.039
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Nov-17 3 3.94 5.29 1.52 17.73
Quarter Ending Feb-18 1 8.67 8.67 8.67 26.77
Year Ending Nov-17 3 9.82 11.74 6.14 20.21
Year Ending Nov-18 3 24.72 34.30 7.56 84.11
Earnings (per share)
Quarter Ending Nov-17 3 -0.02 0.03 -0.08 0.40
Quarter Ending Feb-18 1 0.11 0.11 0.11 0.57
Year Ending Nov-17 3 -0.20 -0.11 -0.29 0.09
Year Ending Nov-18 3 0.22 0.51 -0.28 1.70
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. -- 40.75 45.35
P/E Low - Last 5 Yrs. -- 23.60 24.23
Beta 1.01 0.92 0.91
Price to Sales (TTM) 5.65 3.92 5.95
Price to Book (MRQ) -- 4.85 5.68
Price to Tangible Book (MRQ) -- 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 0.49 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 114.39 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago 98.01 5.15 5.62
Sales - 5 Yr. Growth Rate 34.96 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.90 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago 7.31 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate 14.48 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.48 2.49 2.55
Current Ratio (MRQ) 0.52 3.50 3.56
LT Debt to Equity (MRQ) -- 11.01 13.38
Total Debt to Equity (MRQ) -- 17.15 19.38
Interest Coverage (TTM) -47.40 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 52.12 55.26 54.91
Gross Margin - 5 Yr. Avg. -- 52.35 52.46
EBITD Margin (TTM) -187.01 -- --
EBITD - 5 Yr. Avg -211.00 18.50 15.63
Operating Margin (TTM) -195.92 14.76 6.56
Operating Margin - 5 Yr. Avg. -224.23 14.33 11.00
Pre-Tax Margin (TTM) -205.37 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -233.31 14.64 11.41
Net Profit Margin (TTM) -205.37 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -233.31 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 945,342,213 851,801,741
Net Income/Employee (TTM) -- 110,573,246 99,542,701
Receivable Turnover (TTM) 8.31 5.90 6.13
Inventory Turnover (TTM) -- 2.73 3.56
Asset Turnover (TTM) 0.83 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -170.63 11.86 11.31
Return on Assets - 5 Yr. Avg. -144.35 12.86 12.28
Return on Investment (TTM) -578.34 15.06 14.43
Return on Investment - 5 Yr. Avg. -462.28 16.81 16.07
Return on Equity (TTM) -2,136.30 16.55 16.01
Return on Equity - 5 Yr. Avg. -- 17.82 17.27
  1 Year 3 Year 5 Year
Sales % -45.11 13.73 34.96
EPS (TTM) % -21.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellipharmaceutics International Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.